Skip to content

EBIT at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
-$950M-444%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
-$3.13M-342%
PTH
Pelthos Therapeutics Inc.PTHS
-$13.09M-614%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
-$9.09M+62.9%
HRO
HarrowHROW
-$22.08M-96.6%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$73.23M+15.6%

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M
Free cash flow-$6.0M

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%
Net margin-14.8%
FCF margin-43%

Returns & leverage

See full
Return on equity-36.6%
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Calculated from Journey Medical Corporation’s reported figures.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's EBIT?
Journey Medical Corporation (DERM) reported EBIT of -$1.49M in Q1 2026.
How has Journey Medical Corporation's EBIT changed year-over-year?
Journey Medical Corporation's EBIT increased by 55.1% year-over-year, from -$3.32M to -$1.49M.
What is the long-term trend for Journey Medical Corporation's EBIT?
Over 3 years (2021 to 2025), Journey Medical Corporation's EBIT has grown at a -38.4% compound annual growth rate (CAGR), from -$34.88M to -$8.17M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.